Clinical trial
Simvastatin in the Prevention of Recurrent Pancreatitis, a Triple Blind, Randomized Controlled Trial
NCT04021498 is registered in ClinicalTrials.gov with Enrique de-Madaria as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Simvastatin in the Prevention of Recurrent Pancreatitis, a Triple Blind, Randomized Controlled Trial
- Lead sponsor
- Enrique de-Madaria
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- September 29, 2017
- Completion date
- March 1, 2025
- Enrollment
- 83 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pancreatitis relapsing